Gilla Kaplan - Concepedia

Author

Gilla Kaplan

Also Known As

G Kaplan, G. KAPLAN, G. Kaplan, G. T. Kaplan, G.T. Kaplan, GILLA KAPLAN, Gilla Kaplan, Kaplan, Gilla, Nancy Marín Agudelo

318

Publications

30.1K

Citations

H-Index

192

Concepts

All Affiliations

Rockefeller University University of Cape Town Rutgers, The State University of New Jersey International Center for Public Health South African Tuberculosis Vaccine Initiative

About

Gilla Kaplan is an author at Rockefeller University specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	71	132	17.9K
2	Health Sciences	9	9	813
3	Natural Sciences	4	4	290
4	Engineering	2	2	111
5	Public Health	1	1	42

Gilla Kaplan

228

Publications

28.5K

Citations

H-Index

Page 1

	Year	Citations
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. E P Sampaio, Euzenir Nunes Sarno, Ruth Galilly, The Journal of Experimental Medicine Toxic EffectsImmune RegulationImmunologyCell DeathPathology	1991	1.2K
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. André L. Moreira, E P Sampaio, A Zmuidzinas, The Journal of Experimental Medicine ApoptosisImmunologyCell DeathPathologyPharmacotherapy	1993	1.1K
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response Michael B. Reed, Pilar Domenech, Claudia Manca, Nature Host ResponseMedical MicrobiologyPulmonary TuberculosisPathogenesisImmunology	2004	746
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Laura G. Corral, Patrick Haslett, George W. Muller, PubMed Tnf-alpha MediatesT-regulatory CellImmunologyImmune RegulationImmunologic Mechanism	1999	731
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α Laura G. Corral, Patrick Haslett, George W. Muller, The Journal of Immunology ImmunologyImmune RegulationImmunologic MechanismPharmacotherapyImmunotherapeutics	1999	652
Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens Karim C. El Kasmi, Joseph E. Qualls, John Pesce, Nature Immunology Macrophage BiologyToll-like ReceptorsInflammationHost ResponseAllergy	2008	639
Virulence of a<i>Mycobacterium tuberculosis</i>clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β Claudia Manca, Liana Tsenova, Amy Bergtold, Proceedings of the National Academy of Sciences	2001	596
Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset Patrick Haslett, Laura G. Corral, Matthew L. Albert, The Journal of Experimental Medicine	1998	571
Metformin as adjunct antituberculosis therapy Amit Singhal, Jie Liu, Pavanish Kumar, Science Translational Medicine InflammationGlobal BurdenMtb InfectionClinical TherapeuticAdjunct Antituberculosis Therapy	2014	517
Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. R M Steinman, Gilla Kaplan, M D Witmer, The Journal of Experimental Medicine Laboratory ImmunologyLymphocyte DevelopmentImmunologyPathologyImmune System	1979	516

Page 1